JPRN-UMIN000000502已完成1 期
Phase I/II study of weekly chemotherapy consisting of 5-FU, leucovorin, and Paclitaxel (FLTAX) in patients with metastatic or recurrent gastric cancer. - Phase I/II study of weekly chemotherapy consisting of 5-FU, leucovorin, and Paclitaxel (FLTAX) in patients with metastatic or recurrent gastric cancer.
ational Cancer Center Hospital, Gastrointestinal Oncology Division0 个研究点目标入组 35 人开始时间: 2006年10月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Diabetes with regular use of insulin or under poor control 2) Active ischemic heart disease 3) Severe arrhythmia 4) Symptomatic brain metastasis 5) Alcohol allergy 6) HBs antigen positive or HCV antibody positive 7) Massive abdominal effusion 8) Massive pleural effusin 9) Severe diarrhea 10) History of other active malignancy 11) Pregnancy, the desire to preserve fecundity, or lactating woman 12) Severe mental disorder 13) Need of IVH or enteral nutrition 14) Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
已完成
1 期
Phase I / II Study of Alternating Chemotherapy with Cisplatin plus Nogitecan plus Paclitaxel (PlaTT) and Cisplatin plus Amrubicin plus Paclitaxel (PAT) for Advanced Lung Cancer PatientsAdvanced Lung CancerJPRN-UMIN000012270iigata Lung Cancer Treatment Group18
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
招募中
1 期
Phase I/II trial of combination chemotherapy using TS-1, CPT-11 and cetuximab with radiation in locally advanced rectal cancerRectal cancerJPRN-UMIN000002602Yokohama City University Graduate School of Medicine35
已完成
2 期
A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung CancerJPRN-UMIN000001370West Japan Oncology Group55
已完成
2 期
A Phase II study of combination chemotherapy with TS-1 and Trastuzumab for patients with HER2 positive advanced or recurrent gastric cancer.advanced or recurrent gastric cancerJPRN-UMIN000008220Osaka medical center for cancer and cardiovascular diseases20